EWU Institutional Repository

A Appraisal of Novartis (Bangladesh) Limited

Show simple item record

dc.contributor.author Chowdhury, Faiyaaz Mohammad
dc.date.accessioned 2014-11-21T11:24:12Z
dc.date.available 2014-11-21T11:24:12Z
dc.date.issued 8/16/2010
dc.identifier.uri http://dspace.ewubd.edu/handle/2525/1014
dc.description This thesis submitted in partial fulfillment of the requirements for the degree of Bachelor in Business Administration of East West University, Dhaka, Bangladesh. en_US
dc.description.abstract Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008. Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies. Novartis produces medications for many diseases, cancer and cardiovascular medications that make up the bulk of sales. These medications include blockbuster drugs Gleevec and Diovan, which will benefit people who are more susceptible to cancer or cardiovascular problems. In addition to their current drugs, Novartis has one of the strongest pipelines in the pharmaceutical industry, with over 50 new products set to premier in the next several years. en_US
dc.language.iso en_US en_US
dc.publisher East West University en_US
dc.relation.ispartofseries ;BBA00221
dc.subject Appraisal of Novartis Bangladesh Ltd. en_US
dc.title A Appraisal of Novartis (Bangladesh) Limited en_US
dc.type Thesis en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account